Literature DB >> 9038744

Helicobacter pylori antibody titres in serum, plasma and successively thawed specimens: implications for epidemiological and clinical studies.

D C Pearce1, H G Peach, S J Farish.   

Abstract

Agreement between Helicobacter pylori IgG antibodies measured using the Pylori-set EIA-G kit in serum, plasma and successively thawed specimens was studied and the implications for epidemiological and clinical studies assessed. Plasma titres may differ from serum titres by -6% to +8% and therefore may be substituted for serum. The change in titre around the cut off value was -0.31 (se = 5.7, p = 0.96) per thaw. The estimated maximum drop after three thawings, 34.5, would result in only a small decrease in sensitivity (1.3%). For qualitative epidemiological studies, this additional misclassification rate is relatively small. However, positive titres did reduce over successive thawings, with the estimated maximum drop being 11.4% per thaw. Therefore, thawing does need to be considered as a contributing factor when interpreting titre drops in eradication trials. Baseline and follow up specimens from clinical studies should be thawed once only and tested concurrently.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9038744      PMCID: PMC499655          DOI: 10.1136/jcp.49.12.1017

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  3 in total

1.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

2.  Diagnosis of Helicobacter pylori infection by using pyloriset EIA-G and EIA-A for detection of serum immunoglobulin G (IgG) and IgA antibodies.

Authors:  C Granberg; A Mansikka; O P Lehtonen; H Kujari; R Grönfors; H Nurmi; I Räihä; M R Ståhlberg; R Leino
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

3.  Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori.

Authors:  T U Kosunen; K Seppälä; S Sarna; P Sipponen
Journal:  Lancet       Date:  1992-04-11       Impact factor: 79.321

  3 in total
  3 in total

1.  Human peripheral and gastric lymphocyte responses to Helicobacter pylori NapA and AphC differ in infected and uninfected individuals.

Authors:  H J Windle; Y S Ang; V Athie-Morales; V A Morales; R McManus; D Kelleher
Journal:  Gut       Date:  2005-01       Impact factor: 23.059

2.  Seroconversion and seroreversion in IgG antibodies to Helicobacter pylori: a serology based prospective cohort study.

Authors:  S Rosenstock; T Jørgensen; L Andersen; O Bonnevie
Journal:  J Epidemiol Community Health       Date:  2000-06       Impact factor: 3.710

3.  Multiplex H. pylori Serology and Risk of Gastric Cardia and Noncardia Adenocarcinomas.

Authors:  Ramin Shakeri; Reza Malekzadeh; Dariush Nasrollahzadeh; Michael Pawlita; Michael Pawilta; Gwen Murphy; Farhad Islami; Masoud Sotoudeh; Angelika Michel; Arash Etemadi; Tim Waterboer; Hossein Poustchi; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Farin Kamangar; Christian C Abnet
Journal:  Cancer Res       Date:  2015-09-17       Impact factor: 12.701

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.